The automated nucleic acid extraction systems market is expected to grow at a CAGR of 10.9% from 2022 to 2032.
Nucleic acid extraction systems are in high demand, due to their potential to play an important role as nucleic acid purification systems, and personalized & predictive medicine. Thus, these advantages are projected to propel the nucleic acid extraction system market forward in the coming years.
Automated nucleic acid extraction systems provide high-speed, cleaner, and more consistent nucleic acid extraction.
These systems are designed to run multiple processes at the same time with a reduced error ratio thereby acting as a major driver in the automated nucleic acid extraction systems market.
The rising use of automotive procedures in research and development has boosted the demand for technologically superior automatic nucleic acid extraction systems.
An automated nucleic acid extraction system is preferred to manual alternatives because it provides cleaner and more consistent nucleic acid extraction in less time.
| Attributes | Details |
|---|---|
| Automated Nucleic Acid Extraction Systems Market Size in 2031 | US$ 10.2 Billion |
| Automated Nucleic Acid Extraction Systems Market CAGR from 2022 to 2032 | 10.9% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The isolation and purification in the automated nucleic acid extraction systems are among the fundamental tests in molecular laboratory research and have a vast range of equipment and procedures available for its extraction.
User-friendly interfaces are integrated with the systems to further simplify the processes. The functionality of these systems includes shaking, temperature control, and PCR protocols. Automated nucleic acid extraction systems also help in minimizing the contamination in samples, providing high throughput results in comparatively lesser time and reducing the reagent wastage.
This system finds its application in molecular biology, pathology, forensic science, environmental research, and drug delivery. These automated systems are advanced enough to extract nucleic acid from a variety of samples such as tissue, cell culture, whole blood, serum, plasma, swab, etc.
The nucleic acid extraction system market is predicted to rise steadily as these user–friendly methods reduce sample contamination, provide high throughput results at a rapid pace, and greatly reduce reagent wastage.
Growing laboratory automation and the adoption of superior technology for faster and better results fuel market growth. The technological advantage of automated nucleic acid extraction systems in improving the workflow and decreasing variability also supports the automated nucleic acid extraction systems market.
The high cost of the system, system complexity, limited product acceptability, and high maintenance, and service cost are some of the limiting factors restricting the potential market growth. Low market penetration of automated systems in less developed regions also restricts the global market growth.
Principal Consultant
A number of companies are involved in the manufacturing of these laboratory instruments varying by size, usage, capacity, price, and versatility. Nowadays, most commercial extraction kits are also available in the market-based in line with automated nucleic acid extraction platforms. Continuous enhancements for the system updating also helps in proliferating the market growth for nucleic acid extraction systems.
Companies are adopting strategies for network building and strengthening sales force to increase their product sales. Brand value is also an important parameter affecting the sales of certain companies. New product development, mergers, acquisitions, and partnerships are some of the key trends in the automated nucleic acid extraction systems market.
North America is expected to play a significant role in boosting the automated nucleic acid extraction system market owing to rapid technological improvements and demanding pharmaceutical analytical requirements.
Geographically, North America is the leading market for Automated Nucleic Acid Extraction Systems due to the adoption of laboratory automation, advanced clinical diagnostic services, and high government support in funding research activities.
This is followed by the Western Europe market owing to the more usability in universities and research institutes with a focus on standardized workflow. These two developed regions consume most of the market for automated nucleic acid extraction systems.
Japan also shares a significant market size in the market. Asia Pacific represents a high potential market with the increasing availability of this advanced laboratory equipment, increasing focus towards quality research as well as increasing advancements in diagnostic services.
Latin America followed by the Middle East & Africa represents the lowest market share as well as growth in the automated nucleic acid extraction systems market owing to less spending on biological research and less developed diagnostic facilities.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Some of the players in the Automated Nucleic Acid Extraction Systems market include Qiagen N.V., Roche Molecular Systems, Inc., Analytik Jena AG, Thermofisher Scientific, Accubiomed Co., Ltd., Autogen Inc., DiagCor Bioscience Inc Ltd, Taigen Bioscience Corporation, Bioneer Corporation, and others.
F. Hoffmann-La Roche and DiaSorin S.p.A, Agilent Technologies, Inc., Illumina Inc., Sigma Aldrich Corp., Tecan Group AG, Becton Dickinson and Company, Bio-Rad Laboratories Inc., QIAGEN, PerkinElmer, Inc. are some other key companies operating in the nucleic acid extraction system market.
| Attributes | Details |
|---|---|
| Forecast Period | 2022 to 2032 |
| Historical Data Available For | 2012 to 2020 |
| Market Analysis | US$ Billion for Value |
| By Type | Instruments, Kits and consumables |
| By End Use | Hospitals, Diagnostic Centres, Forensic Laboratories, Pharmaceutical & Biotechnology Companies, Academic Research Institutes |
| By Region | North America; Latin America; Western Europe; Eastern Europe; Asia Pacific; Japan; Middle East and Africa |
| Key Players | Qiagen N.V.; Roche Molecular Systems, Inc.; Analytik Jena AG; Thermofisher Scientific; Accubiomed Co., Ltd.; Autogen Inc.; DiagCor Bioscience Inc Lt; Taigen Bioscience Corporation; Bioneer Corporation |
The automated nucleic acid extraction systems market is expected to witness a CAGR of 10.9% from 2022 to 2032.
The automated nucleic acid extraction systems market by 2027 is estimated to grow over the valuation of US$ 2.29 Billion.
Automated nucleic acid extraction systems spending in 2022 is expected to be US$ 4.46 billion.
The global automated nucleic acid extraction systems market is expected to reach USD 11.32 Billion by 2032.
North America holds the biggest market share in the automated nucleic acid extraction systems market.
1. Executive Summary | Automated Nucleic Acid Extraction Systems Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and Their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyers 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032 4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2017 to 2021 4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2022 to 2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Component 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Component, 2017 to 2021 5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Component, 2022 to 2032 5.3.1. Instrument 5.3.2. Kits 5.3.3. Reagents & Consumables 5.4. Y-o-Y Growth Trend Analysis By Component, 2017 to 2021 5.5. Absolute $ Opportunity Analysis By Component, 2022 to 2032 Deep-dive segmentation will be available in the sample on request 6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Application 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Application, 2017 to 2021 6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Application, 2022 to 2032 6.3.1. Research & Development 6.3.2. Clinical & Commercial 6.4. Y-o-Y Growth Trend Analysis By Application, 2017 to 2021 6.5. Absolute $ Opportunity Analysis By Application, 2022 to 2032 Deep-dive segmentation will be available in the sample on request 7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End User 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2017 to 2021 7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2022 to 2032 7.3.1. Biotechnology Companies 7.3.2. Contract Research Organizations 7.3.3. Academic & Research Institutes 7.3.4. Hospitals 7.3.5. Diagnostic Centers 7.3.6. Forensic Science Laboratories 7.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2021 7.5. Absolute $ Opportunity Analysis By End User, 2022 to 2032 Deep-dive segmentation will be available in the sample on request 8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2017 to 2021 8.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2022 to 2032 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. East Asia 8.3.5. South Asia & Pacific 8.3.6. Middle East and Africa 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2021 9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2022 to 2032 9.2.1. By Country 9.2.1.1. USA 9.2.1.2. Canada 9.2.2. By Component 9.2.3. By Application 9.2.4. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Component 9.3.3. By Application 9.3.4. By End User 9.4. Key Takeaways 10. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2021 10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2022 to 2032 10.2.1. By Country 10.2.1.1. Mexico 10.2.1.2. Brazil 10.2.1.3. Rest of Latin America 10.2.2. By Component 10.2.3. By Application 10.2.4. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Component 10.3.3. By Application 10.3.4. By End User 10.4. Key Takeaways 11. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2021 11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2022 to 2032 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. Italy 11.2.1.3. France 11.2.1.4. United Kingdom 11.2.1.5. Spain 11.2.1.6. BENELUX 11.2.1.7. Russia 11.2.1.8. Rest of Europe 11.2.2. By Component 11.2.3. By Application 11.2.4. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Component 11.3.3. By Application 11.3.4. By End User 11.4. Key Takeaways 12. East Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2021 12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2022 to 2032 12.2.1. By Country 12.2.1.1. China 12.2.1.2. Japan 12.2.1.3. South Korea 12.2.2. By Component 12.2.3. By Application 12.2.4. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Component 12.3.3. By Application 12.3.4. By End User 12.4. Key Takeaways 13. South Asia & Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2021 13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2022 to 2032 13.2.1. By Country 13.2.1.1. India 13.2.1.2. ASEAN 13.2.1.3. Australia and New Zealand 13.2.1.4. Rest of South Asia & Pacific 13.2.2. By Component 13.2.3. By Application 13.2.4. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Component 13.3.3. By Application 13.3.4. By End User 13.4. Key Takeaways 14. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2021 14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2022 to 2032 14.2.1. By Country 14.2.1.1. GCC Countries 14.2.1.2. Turkey 14.2.1.3. South Africa 14.2.1.4. Rest of Middle East and Africa 14.2.2. By Component 14.2.3. By Application 14.2.4. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Component 14.3.3. By Application 14.3.4. By End User 14.4. Key Takeaways 15. Key Countries Market Analysis 15.1. USA 15.1.1. Pricing Analysis 15.1.2. Market Share Analysis, 2021 15.1.2.1. By Component 15.1.2.2. By Application 15.1.2.3. By End User 15.2. Canada 15.2.1. Pricing Analysis 15.2.2. Market Share Analysis, 2021 15.2.2.1. By Component 15.2.2.2. By Application 15.2.2.3. By End User 15.3. Mexico 15.3.1. Pricing Analysis 15.3.2. Market Share Analysis, 2021 15.3.2.1. By Component 15.3.2.2. By Application 15.3.2.3. By End User 15.4. Brazil 15.4.1. Pricing Analysis 15.4.2. Market Share Analysis, 2021 15.4.2.1. By Component 15.4.2.2. By Application 15.4.2.3. By End User 15.5. Germany 15.5.1. Pricing Analysis 15.5.2. Market Share Analysis, 2021 15.5.2.1. By Component 15.5.2.2. By Application 15.5.2.3. By End User 15.6. Italy 15.6.1. Pricing Analysis 15.6.2. Market Share Analysis, 2021 15.6.2.1. By Component 15.6.2.2. By Application 15.6.2.3. By End User 15.7. France 15.7.1. Pricing Analysis 15.7.2. Market Share Analysis, 2021 15.7.2.1. By Component 15.7.2.2. By Application 15.7.2.3. By End User 15.8. United Kingdom 15.8.1. Pricing Analysis 15.8.2. Market Share Analysis, 2021 15.8.2.1. By Component 15.8.2.2. By Application 15.8.2.3. By End User 15.9. Spain 15.9.1. Pricing Analysis 15.9.2. Market Share Analysis, 2021 15.9.2.1. By Component 15.9.2.2. By Application 15.9.2.3. By End User 15.10. BENELUX 15.10.1. Pricing Analysis 15.10.2. Market Share Analysis, 2021 15.10.2.1. By Component 15.10.2.2. By Application 15.10.2.3. By End User 15.11. Russia 15.11.1. Pricing Analysis 15.11.2. Market Share Analysis, 2021 15.11.2.1. By Component 15.11.2.2. By Application 15.11.2.3. By End User 15.12. China 15.12.1. Pricing Analysis 15.12.2. Market Share Analysis, 2021 15.12.2.1. By Component 15.12.2.2. By Application 15.12.2.3. By End User 15.13. Japan 15.13.1. Pricing Analysis 15.13.2. Market Share Analysis, 2021 15.13.2.1. By Component 15.13.2.2. By Application 15.13.2.3. By End User 15.14. South Korea 15.14.1. Pricing Analysis 15.14.2. Market Share Analysis, 2021 15.14.2.1. By Component 15.14.2.2. By Application 15.14.2.3. By End User 15.15. India 15.15.1. Pricing Analysis 15.15.2. Market Share Analysis, 2021 15.15.2.1. By Component 15.15.2.2. By Application 15.15.2.3. By End User 15.16. ASIAN 15.16.1. Pricing Analysis 15.16.2. Market Share Analysis, 2021 15.16.2.1. By Component 15.16.2.2. By Application 15.16.2.3. By End User 15.17. Australia and New Zealand 15.17.1. Pricing Analysis 15.17.2. Market Share Analysis, 2021 15.17.2.1. By Component 15.17.2.2. By Application 15.17.2.3. By End User 15.18. GCC Countries 15.18.1. Pricing Analysis 15.18.2. Market Share Analysis, 2021 15.18.2.1. By Component 15.18.2.2. By Application 15.18.2.3. By End User 15.19. Turkey 15.19.1. Pricing Analysis 15.19.2. Market Share Analysis, 2021 15.19.2.1. By Component 15.19.2.2. By Application 15.19.2.3. By End User 15.20. South Africa 15.20.1. Pricing Analysis 15.20.2. Market Share Analysis, 2021 15.20.2.1. By Component 15.20.2.2. By Application 15.20.2.3. By End User 16. Market Structure Analysis 16.1. Competition Dashboard 16.2. Competition Benchmarking 16.3. Market Share Analysis of Top Players 16.3.1. By Regional 16.3.2. By Component 16.3.3. By Application 16.3.4. By End User 17. Competition Analysis 17.1. Competition Deep Dive 17.1.1. Thermo Fisher Scientific 17.1.1.1. Overview 17.1.1.2. Product Portfolio 17.1.1.3. Profitability by Market Segments 17.1.1.4. Sales Footprint 17.1.1.5. Strategy Overview 17.1.1.5.1. Marketing Strategy 17.1.1.5.2. Product Strategy 17.1.1.5.3. Channel Strategy 17.1.2. Autogen, Inc. 17.1.2.1. Overview 17.1.2.2. Product Portfolio 17.1.2.3. Profitability by Market Segments 17.1.2.4. Sales Footprint 17.1.2.5. Strategy Overview 17.1.2.5.1. Marketing Strategy 17.1.2.5.2. Product Strategy 17.1.2.5.3. Channel Strategy 17.1.3. ELITechGroup 17.1.3.1. Overview 17.1.3.2. Product Portfolio 17.1.3.3. Profitability by Market Segments 17.1.3.4. Sales Footprint 17.1.3.5. Strategy Overview 17.1.3.5.1. Marketing Strategy 17.1.3.5.2. Product Strategy 17.1.3.5.3. Channel Strategy 17.1.4. Analytik Jena AG 17.1.4.1. Overview 17.1.4.2. Product Portfolio 17.1.4.3. Profitability by Market Segments 17.1.4.4. Sales Footprint 17.1.4.5. Strategy Overview 17.1.4.5.1. Marketing Strategy 17.1.4.5.2. Product Strategy 17.1.4.5.3. Channel Strategy 17.1.5. bioMérieux SA 17.1.5.1. Overview 17.1.5.2. Product Portfolio 17.1.5.3. Profitability by Market Segments 17.1.5.4. Sales Footprint 17.1.5.5. Strategy Overview 17.1.5.5.1. Marketing Strategy 17.1.5.5.2. Product Strategy 17.1.5.5.3. Channel Strategy 17.1.6. Aurora Biomed Inc. 17.1.6.1. Overview 17.1.6.2. Product Portfolio 17.1.6.3. Profitability by Market Segments 17.1.6.4. Sales Footprint 17.1.6.5. Strategy Overview 17.1.6.5.1. Marketing Strategy 17.1.6.5.2. Product Strategy 17.1.6.5.3. Channel Strategy 17.1.7. Biosynex Group 17.1.7.1. Overview 17.1.7.2. Product Portfolio 17.1.7.3. Profitability by Market Segments 17.1.7.4. Sales Footprint 17.1.7.5. Strategy Overview 17.1.7.5.1. Marketing Strategy 17.1.7.5.2. Product Strategy 17.1.7.5.3. Channel Strategy 17.1.8. Genolution Inc. 17.1.8.1. Overview 17.1.8.2. Product Portfolio 17.1.8.3. Profitability by Market Segments 17.1.8.4. Sales Footprint 17.1.8.5. Strategy Overview 17.1.8.5.1. Marketing Strategy 17.1.8.5.2. Product Strategy 17.1.8.5.3. Channel Strategy 17.1.9. BioChain Institute Inc. 17.1.9.1. Overview 17.1.9.2. Product Portfolio 17.1.9.3. Profitability by Market Segments 17.1.9.4. Sales Footprint 17.1.9.5. Strategy Overview 17.1.9.5.1. Marketing Strategy 17.1.9.5.2. Product Strategy 17.1.9.5.3. Channel Strategy 17.1.10. Promega Corporation 17.1.10.1. Overview 17.1.10.2. Product Portfolio 17.1.10.3. Profitability by Market Segments 17.1.10.4. Sales Footprint 17.1.10.5. Strategy Overview 17.1.10.5.1. Marketing Strategy 17.1.10.5.2. Product Strategy 17.1.10.5.3. Channel Strategy 17.1.11. QIAGEN N.V. 17.1.11.1. Overview 17.1.11.2. Product Portfolio 17.1.11.3. Profitability by Market Segments 17.1.11.4. Sales Footprint 17.1.11.5. Strategy Overview 17.1.11.5.1. Marketing Strategy 17.1.11.5.2. Product Strategy 17.1.11.5.3. Channel Strategy 17.1.12. Roche Molecular Systems Inc. 17.1.12.1. Overview 17.1.12.2. Product Portfolio 17.1.12.3. Profitability by Market Segments 17.1.12.4. Sales Footprint 17.1.12.5. Strategy Overview 17.1.12.5.1. Marketing Strategy 17.1.12.5.2. Product Strategy 17.1.12.5.3. Channel Strategy 17.1.13. Auto Q Biosciences Limited 17.1.13.1. Overview 17.1.13.2. Product Portfolio 17.1.13.3. Profitability by Market Segments 17.1.13.4. Sales Footprint 17.1.13.5. Strategy Overview 17.1.13.5.1. Marketing Strategy 17.1.13.5.2. Product Strategy 17.1.13.5.3. Channel Strategy 17.1.14. Bioneer Corporation 17.1.14.1. Overview 17.1.14.2. Product Portfolio 17.1.14.3. Profitability by Market Segments 17.1.14.4. Sales Footprint 17.1.14.5. Strategy Overview 17.1.14.5.1. Marketing Strategy 17.1.14.5.2. Product Strategy 17.1.14.5.3. Channel Strategy 17.1.15. Taigen Bioscience Corporation 17.1.15.1. Overview 17.1.15.2. Product Portfolio 17.1.15.3. Profitability by Market Segments 17.1.15.4. Sales Footprint 17.1.15.5. Strategy Overview 17.1.15.5.1. Marketing Strategy 17.1.15.5.2. Product Strategy 17.1.15.5.3. Channel Strategy 17.1.16. Hamilton Robotics 17.1.16.1. Overview 17.1.16.2. Product Portfolio 17.1.16.3. Profitability by Market Segments 17.1.16.4. Sales Footprint 17.1.16.5. Strategy Overview 17.1.16.5.1. Marketing Strategy 17.1.16.5.2. Product Strategy 17.1.16.5.3. Channel Strategy 18. Assumptions & Acronyms Used 19. Research Methodology
Explore Healthcare Insights
View Reports
Automated Nucleic Acid Extraction Systems Market
